Henrietta is a 53-year-old Caucasian female suffering from recurrent laBCC with infiltrative histology on the lip. Diagnosed 17 years before joining the BOLT trial, her first recurrence occurred 3 months prior to baseline evaluation. The progress photos illustrate her response to 6 months of ODOMZO treatment.